CX3CL1 and Alzheimer disease: Insulin/IGF signaling in brains, specifically in hippocampus, has been shown to regulate spatial learning and memory (21), and this activation may partially explain the improved cognitive functions seen in AD mice (PS19 mice) upon overexpressing CX3CL1-ICD (9).